What Is the Life Expectancy of a Person With Hydrocephalus?

There is no single life expectancy for hydrocephalus because the condition spans such different populations, from newborns with congenital fluid buildup to older adults who develop it after a stroke or as part of aging. With modern shunt surgery, most children diagnosed today survive into adulthood, and many reach middle age and beyond. A large long-term follow-up of pediatric patients found that roughly 82 percent were still alive at the 20-year mark, while adults diagnosed with the age-related form tend to have a median survival of about eight years after shunt placement. Those numbers, though, mask enormous variation driven by the underlying cause, the timing of treatment, and the complications that follow.

How Hydrocephalus Looked Before Modern Treatment

Before reliable shunt systems became available in the mid-20th century, hydrocephalus was frequently fatal in childhood. A detailed review of 182 unoperated patients found that more than half of the deaths occurred in the first year of life, and nearly two-thirds happened within the first two years. Of the 92 who survived without surgery, about half had normal or only mildly reduced intelligence, while the rest had moderate to severe cognitive disabilities.¹ That study provides a stark baseline: without intervention, the condition carried devastating mortality and left many survivors with lifelong impairments. The development of ventriculoperitoneal shunts in the 1950s and 1960s transformed the picture, converting what had been a largely fatal diagnosis into a manageable chronic condition for many patients.

Survival Rates in Childhood-Onset Hydrocephalus

For children who receive shunt surgery, survival has improved dramatically. A study tracking children after their first shunt insertion reported overall survival rates of about 96 percent at one year, 91 percent at five years, and 83 percent at ten years.² Those numbers keep climbing when you follow patients further into adulthood. One of the most comprehensive long-term studies, following over 1,500 patients treated in childhood, found that actuarial mortality by age 20 was about 18 percent. Among those who survived past 20, only an additional 6 percent died, with the last recorded death in that cohort happening at age 27.³

Another study followed 69 patients who had been shunted for congenital hydrocephalus in infancy between 1971 and 1987 and found a median age at follow-up of 32 years, with a range of 25 to 42.⁴ These patients were treated with technology that is now decades old; outcomes with current devices and surgical techniques are likely better still. What the data consistently show is that the highest-risk window is the first few years of life, and once a child survives past early childhood with a working shunt, the risk of death from hydrocephalus itself drops considerably.

What Determines Whether a Child Does Well or Poorly

The underlying cause of hydrocephalus matters more than almost any other factor. Children whose hydrocephalus is congenital and not associated with other major brain abnormalities tend to fare better than those whose hydrocephalus results from infection or from myelomeningocele, a severe form of spina bifida. In one analysis, myelomeningocele and infection were the strongest risk factors for death among shunted children.² A study of infants with acquired hydrocephalus found that those whose fluid buildup followed a brain hemorrhage had better outcomes than those with other causes, while hydrocephalus linked to inherited metabolic disorders carried a particularly poor prognosis.⁵ Delayed surgical treatment and severe ventricular dilation at the time of surgery were also linked to worse outcomes in that study.

Genetic forms of hydrocephalus follow their own trajectory. Mutations in the L1CAM gene cause a group of related conditions sometimes called CRASH syndrome. Mutations that truncate the protein in its outer portion tend to produce more severe hydrocephalus, deeper intellectual disability, and a higher likelihood of early death compared with milder mutations that affect only the protein’s internal portion.⁶ For families dealing with a genetic diagnosis, the specific mutation can give clinicians a rough sense of what to expect.

When hydrocephalus is detected before birth, outcomes are mixed but have improved over the decades. An analysis of fetal hydrocephalus cases found that among those who were not terminated and could be evaluated long-term, about 17 percent died, 21 percent had severe intellectual disability, and 23 percent had a good outcome. The long-term result depended heavily on whether other brain abnormalities or genetic syndromes were present.⁷

What Causes Death in Pediatric Patients

A finding that often surprises families is that most deaths in children with hydrocephalus are not caused by the hydrocephalus itself. A review of pediatric hydrocephalus mortality found that the majority of deaths were related to other medical conditions the child had alongside hydrocephalus. Of the deaths directly attributable to hydrocephalus, about half were caused by shunt complications and roughly a third occurred after medical teams and families decided to stop treatment because the predicted outcome was very poor.⁸ A review of outcomes literature placed the mortality rate from hydrocephalus and its treatments specifically at between 0 and 3 percent, depending on how long patients were followed.⁹

Among the shunt-related deaths, infection and acute shunt malfunction are the two main killers. One retrospective study found that of 23 deaths related to shunt treatment, 18 involved shunt infection and 5 involved acute shunt dysfunction.¹⁰ Shunt infections are treatable when caught early, but they require hospitalization, removal of the infected hardware, antibiotic therapy, and eventual re-implantation. Each revision carries its own risks.

The Shunt Problem

Shunts save lives, but they are far from perfect devices. They are essentially narrow tubes that drain excess cerebrospinal fluid from the brain’s ventricles to another body cavity, usually the abdomen. They can become blocked, disconnected, or infected, and when they fail, the consequences range from slowly worsening headaches to a life-threatening emergency. The overall failure rate requiring at least one revision is substantial: one long-term study put it at about 46 percent, with the vast majority of revisions happening in the first six months after placement.¹¹ Pediatric patients had a much higher revision rate than adults in that study, roughly 78 percent versus 33 percent.

More recent data from a large neurosurgical center found one-year shunt survival of about 72 percent in adults, with an average time to failure of about 62 days when shunts did fail. Reassuringly, no patients in that cohort died from shunt failure itself.¹² When shunt complications do lead to hospitalization, though, the stakes are real: one study reported that hospitalization for a shunt complication carried a mortality rate of about 2.7 percent.¹³ And within 30 days of initial shunt placement, one multicentre audit found an all-cause mortality rate of 6 percent, though none of those deaths were directly caused by the procedure.¹⁴

The cumulative burden of multiple revisions matters for long-term quality of life and likely for survival too. Each surgery carries a small risk of infection, and shunt infections themselves contribute to cognitive decline and additional mortality. In pediatric patients, shunt infection has been linked to substantial morbidity and reduced quality of life beyond the immediate medical crisis.¹⁵

Endoscopic Third Ventriculostomy as an Alternative

For some patients, an internal bypass can replace a shunt altogether. Endoscopic third ventriculostomy, or ETV, involves creating a small hole in the floor of a brain ventricle so fluid can drain naturally into the spaces around the brain. In adults, ETV has been successful in about three-quarters of cases. Among those in whom the procedure failed, most went on to receive a conventional shunt.¹⁶

In children, the picture is more nuanced. A large-scale analysis found that ETV had higher early failure rates than shunts, but after about three months, the failure rate for ETV dropped below that of shunts. The interpretation is that ETV may offer a long-term treatment survival advantage for appropriate candidates, even though it is riskier in the short term.¹⁷ Still, treatment failure with either approach occurs in more than half of pediatric patients over time. One study found failure rates of 55 percent for ETV and 58 percent for shunts, with prematurity and longer surgical duration being risk factors for shunt failure.¹⁸ The advantage of a successful ETV is that it eliminates hardware from the body entirely, removing the ongoing risk of shunt malfunction and the need for future revisions.

Normal Pressure Hydrocephalus in Older Adults

Normal pressure hydrocephalus, or NPH, is a different condition in many respects. It typically develops in people over 60 and causes a distinctive triad of symptoms: difficulty walking, urinary incontinence, and cognitive decline. Because these symptoms overlap with dementia and normal aging, it is often diagnosed late or missed entirely. The “normal pressure” label refers to the fact that spinal fluid pressure readings can fall within the typical range even though the ventricles are enlarged.

A study of 200 patients with idiopathic NPH who underwent shunt surgery found a median overall survival of 7.7 years, with women surviving longer than men (8.8 versus 5.9 years). Nearly half of the patients died during the follow-up period, with the most common causes of death being senility, pneumonia, and cancer.¹⁹ Given that the average age at shunt placement was about 78, a median survival of nearly eight years is not dramatically different from general population life expectancy at that age, though it is shorter. A separate 10-year study found that shunted NPH patients had a two-and-a-half-fold increased risk of death compared with age-matched controls, with 50 percent of NPH patients dead after 10 years versus 24 percent of controls.²⁰

What kills NPH patients is worth noting. Cardiovascular disease was the most common cause of death, occurring at twice the rate seen in controls. Falls were another major contributor, and most of the NPH patients who died from falls had subdural hematomas, which are bleeds between the brain and skull. That finding makes sense: these patients already have gait instability, and shunt placement can slightly increase the space around the brain, making blood vessels more vulnerable to tearing during a fall.²⁰ The overall comorbidity burden, measured by how many other chronic conditions a patient has, was an independent predictor of survival in shunted NPH patients. Interestingly, though, comorbidity burden did not predict whether the shunt would actually improve symptoms like walking or continence.²¹ In other words, even sicker patients can benefit functionally from shunting, even if their overall life expectancy is more limited.

Slit Ventricle Syndrome and Chronic Shunt Complications

Some long-term shunt patients develop a paradoxical and dangerous condition. Over years or decades, the ventricles can collapse to a very small size around the shunt catheter, a situation called slit ventricle syndrome. When the shunt then partially blocks, intracranial pressure can rise to dangerously high levels, but brain imaging looks deceptively normal because the ventricles are already so small they cannot expand. Emergency physicians may not recognize the danger because the classic sign of hydrocephalus, enlarged ventricles on a scan, is absent.²²

In its most severe form, this condition can cause rapid loss of consciousness and respiratory arrest. Treatment typically involves emergency decompression surgery or adjustment of the shunt valve system.²³ Slit ventricle syndrome is one reason that adults who were shunted as children need lifelong neurosurgical follow-up, even when they feel well. Shunt dependency does not end; it just changes character over time.

Sudden Unexpected Death

Perhaps the most unsettling aspect of long-term hydrocephalus is the rare occurrence of sudden, unexplained death in apparently stable patients. A case series described four young adults, aged 20 to 28, with chronic hydrocephalus from various causes who collapsed suddenly with cardiac and respiratory failure and could not be resuscitated. None had complained of headaches or seizures beforehand, and post-mortem examinations could not establish a definitive cause of death.²⁴ The mechanism is not well understood, but hypotheses include intermittent brainstem compression or sudden shunt malfunction that escalates too quickly for the patient to seek help. These events are rare, but their existence underscores the lifelong nature of the condition’s risks.

How Geography Shapes Outcomes

Everything discussed above assumes access to a well-equipped neurosurgical center. In sub-Saharan Africa and other resource-limited settings, the picture is very different. A study comparing ETV outcomes between Uganda and developed nations found that the risk of the procedure being abandoned mid-operation was dramatically higher in Uganda. However, when the operation was completed successfully and patient prognostic factors were accounted for, there was no meaningful difference in long-term treatment survival.²⁵ That finding suggests the biology of hydrocephalus is the same everywhere; what differs is whether patients can reach a surgeon with the right tools and experience. In many low-income countries, children with hydrocephalus still die or suffer severe disability simply because they never receive treatment.

Acquired Hydrocephalus After Brain Injury or Stroke

Hydrocephalus does not only arise from congenital causes or aging. It can develop after a traumatic brain injury or a hemorrhagic stroke, sometimes weeks or months after the initial event. A large nationwide cohort study in South Korea found that the rate of developing hydrocephalus was roughly 19 times higher in people who had experienced a brain injury or hemorrhagic stroke compared with matched controls. Hemorrhagic stroke carried an even higher risk than traumatic brain injury. The elevated risk persisted for up to six years after the initial diagnosis and was particularly high in younger individuals, smokers, and people who drank alcohol.²⁶ Life expectancy for these patients depends largely on their recovery from the original injury and how quickly the hydrocephalus is identified and treated. Because the symptoms of developing hydrocephalus, such as worsening confusion, difficulty walking, or drowsiness, overlap with the expected aftermath of a brain injury, the diagnosis can be delayed.

For anyone who has survived a serious head injury or brain hemorrhage, the practical takeaway is that new or worsening neurological symptoms in the months that follow deserve a fresh evaluation rather than being attributed to the original event alone.